Literature DB >> 9234046

Smoked heroin and cocaine base (speedball) combinations in rhesus monkeys.

A J Mattox1, S S Thompson, M E Carroll.   

Abstract

The purpose of this investigation was to compare the self-administration of heroin and cocaine base, alone and in combination, in rhesus monkeys (Macaca mulatta) self-administering a combination of heroin (0.1 mg/kg/delivery) and cocaine base (1.0 mg/kg/delivery) via the smoking route. Smoke deliveries were contingent on completion of a chained fixed ratio (FR; lever press), FR 5 (inhalation) schedule. The lever press FR values (64, 128, 256, 512, and 1024) represented increasing drug price. Demand functions (Consumption X price) were obtained for the heroin and cocaine combination and compared with previously determined demand functions for smoked heroin and cocaine alone. As the FR increased and the number of responses emitted increased, the number of drug deliveries decreased. The demand functions were not different for heroin versus cocaine alone or for the cocaine alone versus the cocaine-heroin combination. However, the demand for heroin alone was significantly less than the demand for the cocaine-heroin combination, suggesting that smoked cocaine base enhances the behavioral effects of smoked heroin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234046     DOI: 10.1037//1064-1297.5.2.113

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  17 in total

1.  Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.

Authors:  Mark A Smith; Keith A Gordon; Christopher K Craig; Paul A Bryant; M Eric Ferguson; Adam M French; Jason D Gray; Jacob M McClean; Jonathan C Tetirick
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

2.  Self-administration of cocaine and remifentanil by monkeys: choice between single drugs and mixtures.

Authors:  Kevin B Freeman; William L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  2010-12-30       Impact factor: 4.530

3.  Reinforcing effects of smoked methamphetamine in rhesus monkeys.

Authors:  Jennifer L Newman; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2006-08-26       Impact factor: 4.530

4.  Female rats self-administer heroin by vapor inhalation.

Authors:  Arnold Gutierrez; Jacques D Nguyen; Kevin M Creehan; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2020-10-24       Impact factor: 3.533

5.  Self-administered heroin and cocaine combinations in the rat: additive reinforcing effects-supra-additive effects on nucleus accumbens extracellular dopamine.

Authors:  James E Smith; Conchita Co; Michael D Coller; Scott E Hemby; Thomas J Martin
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

6.  Speedball induced changes in electrically stimulated dopamine overflow in rat nucleus accumbens.

Authors:  Lindsey P Pattison; Keith D Bonin; Scott E Hemby; Evgeny A Budygin
Journal:  Neuropharmacology       Date:  2010-09-24       Impact factor: 5.250

7.  Demand curves for hypothetical cocaine in cocaine-dependent individuals.

Authors:  Natalie R Bruner; Matthew W Johnson
Journal:  Psychopharmacology (Berl)       Date:  2013-11-12       Impact factor: 4.530

8.  Self-administration of cocaine-pentobarbital mixtures by rhesus monkeys.

Authors:  W L Woolverton; Zhixia Wang
Journal:  Drug Alcohol Depend       Date:  2008-12-03       Impact factor: 4.492

9.  Self-administration of cocaine and remifentanil by monkeys under concurrent-access conditions.

Authors:  Sally L Huskinson; Kevin B Freeman; William L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  2014-06-26       Impact factor: 4.530

10.  Self-administration of drug mixtures by monkeys: combining drugs with comparable mechanisms of action.

Authors:  W L Woolverton; Zhixia Wang; Theresa Vasterling; F Ivy Carroll; Ronald Tallarida
Journal:  Psychopharmacology (Berl)       Date:  2007-11-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.